Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Telix Pharmaceuticals Limited - American Depositary Shares
(NQ:
TLX
)
8.090
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 23, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
82
Open
8.090
Bid (Size)
8.000 (100)
Ask (Size)
9.000 (200)
Prev. Close
8.090
Today's Range
8.090 - 8.090
52wk Range
7.720 - 30.36
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
TLX DEADLINE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
December 23, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 22, 2025
From
Schall Law
Via
GlobeNewswire
Performance
YTD
-46.1%
-46.1%
1 Month
-11.8%
-11.8%
3 Month
-26.0%
-26.0%
6 Month
-50.7%
-50.7%
1 Year
-47.5%
-47.5%
More News
Read More
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Resubmissions
December 21, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Telix Pharmaceuticals
December 21, 2025
From
Faruqi & Faruqi, LLP
Via
Business Wire
TLX INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
December 19, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 18, 2025
From
Schall Law
Via
GlobeNewswire
Robbins LLP Reminds Telix Pharmaceuticals Ltd. Stockholders About the January 9, 2026 Lead Plaintiff Deadline – Contact Us Today for Information About the TLX Class Action
December 15, 2025
From
Robbins LLP
Via
Business Wire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 15, 2025
From
Schall Law
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 12, 2025
From
Schall Law
Via
GlobeNewswire
TELIX CLASS ACTION REMINDER: Bragar Eagel & Squire, P.C. Reminds Telix Pharmaceuticals Limited Stockholders to Contact the Firm Regarding Their Rights
December 11, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
Telix and Varian Announce Strategic Theranostics-EBRT Clinical Collaboration
December 10, 2025
From
Telix Pharmaceuticals Limited
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 09, 2025
From
Schall Law
Via
GlobeNewswire
ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
December 05, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 05, 2025
From
Schall Law
Via
GlobeNewswire
TLX Class Action Reminder: Telix Pharmaceuticals Ltd. Stockholders Should Contact Robbins LLP for Information About Leading the Class Action Against TLX
December 04, 2025
From
Robbins LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors of Telix, Freeport, and Primo Brands to Contact the Firm About their Rights Before Lead Plaintiff Deadlines
December 02, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
December 02, 2025
From
Schall Law
Via
GlobeNewswire
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
December 01, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Telix Pharmaceuticals
November 29, 2025
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors of Telix Pharmaceuticals and Firefly Aerospace to Contact the Firm About their Rights Before Lead Plaintiff Deadlines
November 28, 2025
From
Bragar Eagel & Squire
Via
GlobeNewswire
ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
November 28, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
November 28, 2025
From
Schall Law
Via
GlobeNewswire
ROSEN, THE FIRST FILING FIRM, Encourages Telix Pharmaceuticals Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – TLX
November 25, 2025
From
The Rosen Law Firm PA
Via
GlobeNewswire
TLX Investors Have Opportunity to Lead Telix Pharmaceuticals Limited Securities Fraud Lawsuit with the Schall Law Firm
November 25, 2025
From
Schall Law
Via
GlobeNewswire
Levi & Korsinsky Reminds Telix Pharmaceuticals Ltd. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of January 9, 2026 - TLX
November 25, 2025
Via
NewMediaWire
Topics
Economy
Fraud
Lawsuit
Frequently Asked Questions
Is Telix Pharmaceuticals Limited - American Depositary Shares publicly traded?
Yes, Telix Pharmaceuticals Limited - American Depositary Shares is publicly traded.
What exchange does Telix Pharmaceuticals Limited - American Depositary Shares trade on?
Telix Pharmaceuticals Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Telix Pharmaceuticals Limited - American Depositary Shares?
The ticker symbol for Telix Pharmaceuticals Limited - American Depositary Shares is TLX on the Nasdaq Stock Market
What is the current price of Telix Pharmaceuticals Limited - American Depositary Shares?
The current price of Telix Pharmaceuticals Limited - American Depositary Shares is 8.090
When was Telix Pharmaceuticals Limited - American Depositary Shares last traded?
The last trade of Telix Pharmaceuticals Limited - American Depositary Shares was at 12/23/25 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
